Rackspace Technology (RXT) has had the highest return since January 1, 2026 by a US stock with an IPO date in 2020, returning 544.1%.
| ASSET | % RETURN |
|---|---|
Rackspace Technology (RXT) | 544.14% |
Zentalis Pharmaceuticals Llc (ZNTL) | 217.04% |
Enliven Therapeutics (ELVN) | 172.9% |
Tango Therapeutics (TNGX) | 165.54% |
Biodesix (BDSX) | 132.99% |
Spire Global (SPIR) | 130.59% |
Obsidian Energy (OBE) | 114.68% |
Nanobiotix (NBTX) | 112.42% |
QVC (QVCGP) | 83.06% |
Revolution Medicines (RVMD) | 81.49% |
Shattuck Labs (STTK) | 81.37% |
Alx Oncology Holdings (ALXO) | 79.65% |
Occidental Petroleum (OXY.WT) | 78.18% |
Nkarta (NKTX) | 75.4% |
Hafnia (HAFN) | 72.74% |
Allegro Microsystems (ALGM) | 69.89% |
C4 Therapeutics (CCCC) | 62.56% |
American Well (AMWL) | 61.35% |
Prelude Therapeutics (PRLD) | 60% |
TAO Synergies (TAOX) | 56.62% |
Relay Therapeutics (RLAY) | 54.85% |
Atea Pharmaceuticals (AVIR) | 54.49% |
Mediaco (MDIA) | 53.77% |
Sprott (SII) | 48.1% |
908 Devices (MASS) | 45.16% |